RAGE/AGER Antibody (175410)

R&D Systems | Catalog # MAB1179

R&D Systems

Key Product Details

Species Reactivity

Validated:

Mouse, Rat

Cited:

Human, Mouse, Rat, Hamster, Transgenic Mouse

Applications

Validated:

Immunohistochemistry, Western Blot

Cited:

Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Western Blot, Neutralization, Flow Cytometry, Immunocytochemistry, Immunoprecipitation, Bioassay

Label

Unconjugated

Antibody Source

Monoclonal Rat IgG2A Clone # 175410
Loading...

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse RAGE
Gly23-Ala342
Accession # NP_031451

Specificity

Detects mouse and rat RAGE in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human RAGE is observed.

Clonality

Monoclonal

Host

Rat

Isotype

IgG2A

Scientific Data Images for RAGE/AGER Antibody (175410)

Detection of Mouse RAGE antibody by Western Blot.

Detection of Mouse RAGE by Western Blot.

Western blot shows lysates of mouse lung tissue. PVDF membrane was probed with 2 µg/mL of Rat Anti-Mouse/Rat RAGE Monoclonal Antibody (Catalog # 1179) followed by HRP-conjugated Anti-Rat IgG Secondary Antibody (Catalog # HAF005). Specific bands were detected for RAGE and mature RAGE at approximately 50 and 38 kDa, respectively (as indicated). This experiment was conducted under non-reducing conditions and using Immunoblot Buffer Group 1.
RAGE antibody in Mouse Lung by Immunohistochemistry (IHC-Fr).

RAGE in Mouse Lung.

RAGE was detected in perfusion fixed frozen sections of adult mouse lung using Rat Anti-Mouse/Rat RAGE Monoclonal Antibody (Catalog # MAB1179) at 10 µg/mL overnight at 4 °C. Tissue was stained using the Northern-Lights™ 557-conjugated Anti-Rat IgG Secondary Antibody (red; Catalog # NL013) and counterstained with DAPI (blue). View our protocol for Fluorescent IHC Staining of Frozen Tissue Sections.
Detection of RAGE by Immunohistochemistry

Detection of RAGE by Immunohistochemistry

YAP/TAZ activation in secretory cells enforces fate conversion into AT1 cells, but bypasses basal or AT2 cellsARepresentative IF images showing the expression of epithelial cell marker E‐cadherin and apoptosis marker TUNEL in Scgb1a1 lineage‐labeled tdTomato+ cells of control and Lats1/2 dKO lungs. Tomato (for secretory lineage, red), E‐cadherin (for epithelial cell, white), TUNEL (for apoptotic cells, green), and DAPI (blue). Scale bars, 100 μm.BRepresentative IF images showing the expression of basal cell marker P63 in Scgb1a1 lineage‐labeled tdTomato+ cells in control and Lats1/2 dKO lungs. Tomato (for secretory lineage, red), P63 (green), and DAPI (blue). Scale bars, 100 μm.CRepresentative IF images showing the expression of AT2 cell marker SPC in Scgb1a1 lineage‐labeled tdTomato+ cells in control and Lats1/2 dKO lungs. Tomato (for secretory lineage, red), SPC (green), and DAPI (blue). Scale bars, 100 μm.D, ERepresentative IF images showing the expression of AT1 cell markers T1 alpha (D), AGER (E), and endothelial marker VECAM (E) in Scgb1a1 lineage‐labeled tdTomato+ cells in control and Lats1/2 dKO lungs. Tomato (for secretory lineage, red), T1 alpha (D, green), AGER (E, green), VECAM (E, white), and DAPI (blue). Scale bars, 100 μm.FQuantification of Scgb1a1 lineage‐labeled tdTomato+AGER+ AT1 cells in (E). Data are presented as mean ± SEM (n = 5 mice for each group). *P < 0.05, ***P < 0.001 (Student’s t‐test). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.15252/embj.2021109365), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of RAGE by Immunohistochemistry

Detection of RAGE by Immunohistochemistry

Double-positive cells in Sftpc-CreER; LSL-KrasG12D-induced lung adenocarcinoma are tumor-propagating cells and forms tumors upon transplantation. A, Experimental outline for growing cells in 3D organoid culture. B, FACS scatter plot showing single (type I or type II) and double-positive population sorted from Sftpc-CreER; LSL-KrasG12D; TdTomato mice. Type I (TdTm−Pdpn+), type II (TdTm+ Pdpn−), and double-positive (type I/II+; TdTm+Pdpn+) fractions were sorted. C, Brightfield images of 3D organoid cultures from different indicated sorted populations on day 14. Colony number (D) and colony size (E) was quantified using ImageJ software. F, 3D organoid culture from double-positive cells on day 14 in red channel. G, Immunofluorescent image on day 14 of organoid culture showing double-positive cells differentiate into type I and type II cells. Ki67 (H) and TTF1 (I) staining of 3D organoid culture. J, Representative H&E staining of tumors sections which were obtained after subcutaneous transplantation of double-positive (type I/II+) cells. Right panel shows higher magnification of boxed area in left panels. K, Representative IHC images of tumor sections for TTF1. Right panel shows higher magnification of boxed area in left panels. L, Representative immunofluorescent image for in red channel showing Tdtomato expression in tumor obtained after transplantation. M, Representative IF images for Sftpc and Rage staining. Right panel shows higher magnification of boxed area in left panels. Results shown in B, F, G, H, I, J, K, L, and M are representative of three independent experiments. D and E represent data from three independent experiments. Error bars represent the mean ± SEM values and significance is defined as *, P ≤ 0.05; **, P ≤ 0.01; and ***, P ≤ 0.001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37882674), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of RAGE by Immunohistochemistry

Detection of RAGE by Immunohistochemistry

SARS-CoV-2 distribution and viral target cells in the lungs from each mouse model. (A) SARS-CoV-2 distribution in the lungs analysed using in situ hybridisation at 2, 5, and 7 dpi with 1 × 105 PFU SARS-CoV-2. (B) Representative confocal immunofluorescence micrographs of the lungs of K18-hACE2 (left), SFTPB-hACE2 (middle), and SCGB1A1-hACE2 (right) mice from the PBS-treated control group (top) and SARS-CoV-2-infected group (bottom) at 2 dpi. SARS-CoV-2 N-protein-positive cells are stained red, and type 1 alveolar (Ager), type 2 alveolar (Lamp3), or club (SCGB1A1) cells are stained green. Nuclei of cells are stained blue with DAPI. The scale bars are 100 μm. (C) Quantification of the percentage of infected cells from the lungs of K18-hACE2 (left), SFTPB-hACE2 (middle), and SCGB1A1-hACE2 (right) mice analysed from the confocal immunofluorescence micrographs shown in (B). Lung sections from SARS-CoV-2-infected mice at 2 dpi stained with anti-SARS-CoV-2 N-protein antibody and one of anti-Ager, anti-Lamp3, anti-SCGB1A1, anti-Muc5ac, or anti-tubulin antibodies. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36457995), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of RAGE by Immunohistochemistry

Detection of RAGE by Immunohistochemistry

Sustained activation of YAP/TAZ drives the fate conversion of secretory cells into AT1 cells via DATP cell statesAExperimental design for isolating Scgb1a1 lineage‐labeled cells from control and Lats1/2 dKO lungs at indicated time points post tamoxifen treatment. Isolated cells were subjected to scRNA‐seq analysis.BClusters of Scgb1a1 lineage‐labeled cells from 10XGenomics 3’ single‐cell RNA sequencing (scRNA‐seq) analysis visualized by Uniform Manifold Approximation and Projection (UMAP), assigned by specific colors at day 5 and 14 post tamoxifen treatment. The number of cells in the individual cluster is depicted in the figure.CDistribution of each cluster across indicated time points after tamoxifen treatment.DBar graph showing the percentage of secretory, DATPs, and AT1 cell clusters in control and Lats1/2 dKO lungs at day 5 and 14 post tamoxifen treatment.EBlob plot depicting selected marker genes in cell clusters. Dot size encodes the percentage of cells expressing the gene, and color encodes the average per cell gene expression level.FPseudotime ordering of Scgb1a1 lineage‐labeled cells colored by cluster assignment (right) according to diffusion pseudotime (DPT, left) order.G, HRepresentative IF images of control and Lats1/2 dKO airways at indicated time points post tamoxifen treatment. Tomato (for Scgb1a1 lineage, red), CLDN4 (for DATPs, white), CC10 (G, green), AGER (H, for AT1 cell, green), and DAPI (blue). Scale bar, 100 μm.IQuantification of Scgb1a1 lineage‐labeled tdTomato+CLDN4+ DATPs in (G and H). Data are presented as mean ± SEM (n = 5 mice for each genotype). ***P < 0.001 (Student’s t‐test). Image collected and cropped by CiteAb from the following open publication (https://link.springer.com/10.15252/embj.2021109365), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of RAGE by Western Blot

Detection of RAGE by Western Blot

L-4F treatment decreases RAGE/ED1/HMGB-1, and PAI-1 in the ischemic brain in T2DM mice 4 days after MCAo. (A–D) HMGB-1 immunostaining and quantitative data; (E,F) RAGE/ED1/HMGB-1 WB assay and quantitative data; (G,H) TNF alpha /PAI-1 WB assay and quantitative data; (I) TNF alpha /PAI-1 RT-PCR data. Scale bar in (A–C) = 50 μm; ∗p < 0.05, n = 11/group in (A–D); n = 6/group in (A–I). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31708728), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of RAGE by Immunocytochemistry/ Immunofluorescence

Detection of RAGE by Immunocytochemistry/ Immunofluorescence

Immunofluorescent staining revealed increased RAGE expression in TG mouse lungs ((F,K) vs. A) and diminished localization of NKX2.1 ((G,L) vs. B) and alpha smooth muscle actin (ACTA 2; (H,M) vs. C). DAPI counterstained images (D,I,N) and merged images that contains RAGE, NKX2.1, ACTA 2, and DAPI (E,J,O) are also depicted. All images are at 400× original magnification and scale bars represent 50 μm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37489334), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of RAGE by Western Blot

Detection of RAGE by Western Blot

(A) Doxycycline (Dox)-inducible expression of RAGE in transgenic (TG) mice required a reverse tetracycline transactivator (rtTA) localized to respiratory epithelial cells via the human surfactant protein (hSP)-C promoter. The rtTA complexed with Dox and activated Tet-inducible RAGE expression. (B) Representative immunoblotting revealed increased expression of RAGE in RAGE TG mice fed Dox compared to Dox-exposed control animals. Actin was used as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37489334), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for RAGE/AGER Antibody (175410)

Application
Recommended Usage

Immunohistochemistry

8-25 µg/mL
Sample: Perfusion fixed frozen sections of adult mouse lung

Western Blot

2 µg/mL
Sample: Mouse lung tissue
Under non-reducing conditions only

Reviewed Applications

Read 1 review rated 5 using MAB1179 in the following applications:

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: RAGE/AGER

Advanced glycation endproducts (AGE) are adducts formed by the non-enzymatic glycation or oxidation of macromolecules (1). AGE forms during aging and its formation is accelerated under pathophysiologic states such as diabetes, Alzheimer’s disease, renal failure and immune/inflammatory disorders. Receptor for Advanced Glycation Endoproducts (RAGE), named for its ability to bind AGE, is a multiligand receptor belonging the immunoglobulin (Ig) superfamily. Besides AGE, RAGE binds amyloid beta -peptide, S100/calgranulin family proteins, high mobility group B1 (HMGB1, also know as amphoterin) and leukocyte integrins (1, 2). The mouse RAGE gene encodes a 403 amino acid (aa) residue type I transmembrane glycoprotein with a 22 aa signal peptide, a 319 aa extracellular domain containing a Ig-like V‑type domain and two Ig-like Ce-type domains, a 21 aa transmembrane domain and a 41 aa cytoplasmic domain (3). The V‑type domain and the cytoplasmic domain are important for ligand binding and for intracellular signaling, respectively. Two alternative splice variants, lacking the V‑type domain or the cytoplasmic tail, are known (1, 4). RAGE is highly expressed in the embryonic central nervous system (5). In adult tissues, RAGE is expressed at low levels in multiple tissues including endothelial and smooth muscle cells, mononuclear phagocytes, pericytes, microglia, neurons, cardiac myocytes and hepatocytes (6). The expression of RAGE is upregulated upon ligand interaction. Depending on the cellular context and interacting ligand, RAGE activation can trigger differential signaling pathways that affect divergent pathways of gene expression (1, 7). RAGE activation modulates varied essential cellular responses (including inflammation, immunity, proliferation, cellular adhesion and migration) that contribute to cellular dysfunction associated with chronic diseases such as diabetes, cancer, amyloidoses, and immune or inflammatory disorders (1).

References

  1. Schmidt, A. et al. (2001) J. Clin. Invest. 108:949.
  2. Chavakis, T. et al. (2003) J. Exp. Med. 198:507.
  3. Renard, C. et al. (1997) Mol. Pharmacol. 52:54.
  4. Yonekura, H. et al. (2003) Biochem. J. 370:1097.
  5. Hori, O. et al. (1995) J. Biol. Chem. 270:25752.
  6. Brett, J. et al. (1993) Am. J. Pathol. 143:1699.
  7. Valencia, J.V. et al. (2004) Diabetes 53:743.

Long Name

Receptor for Advanced Glycation End Products

Alternate Names

AGER, SCARJ1

Entrez Gene IDs

177 (Human); 11596 (Mouse); 81722 (Rat); 403168 (Canine)

Gene Symbol

AGER

UniProt

Additional RAGE/AGER Products

Product Documents for RAGE/AGER Antibody (175410)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for RAGE/AGER Antibody (175410)

For research use only

Citations for RAGE/AGER Antibody (175410)

Customer Reviews for RAGE/AGER Antibody (175410) (1)

5 out of 5
1 Customer Rating
5 Stars
100%
4 Stars
0%
3 Stars
0%
2 Stars
0%
1 Stars
0%

Have you used RAGE/AGER Antibody (175410)?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 for a review with an image

$10/€7/£6/$10CAN/¥1110 for a review without an image

Submit a review
Amazon Gift Card

Customer Images


Showing  1 - 1 of 1 review Showing All
Filter By:
  • Mouse/Rat RAGE Antibody
    Name: Anonymous
    Application: Immunofluorescence
    Sample Tested: Kidney tissue
    Species: Mouse
    Verified Customer | Posted 08/25/2021
    RAGE/AGER Antibody (175410) MAB1179

There are no reviews that match your criteria.

Showing  1 - 1 of 1 review Showing All

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies